BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma

BackgroundsImmunotherapy is effective in a subset of head and neck squamous cell carcinoma (HNSCC). However, the unfavorable response rate and inadequate biomarkers for stratifying patients have primarily limited its clinical application. Considering transcriptional factors (TFs) play essential role...

Full description

Bibliographic Details
Main Authors: Xue Pan, Xun Xu, Lixuan Wang, Siyuan Zhang, Yingyao Chen, Rongchun Yang, Xijuan Chen, Bin Cheng, Juan Xia, Xianyue Ren
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
HNSCC
BASP1
immunotherapy
CD8+ T cells
ferroptosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1021262/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1021262/full

Similar Items